|
Lipids
Citations 181-190 of 397 total displayed.
|
Past content
(since Feb 1999):
|
- Clinical Investigations and Reports
Sulfatides: Targets for Anti-Phospholipid Antibodies
- M. Merten, S. Motamedy, S. Ramamurthy, F.C. Arnett, and P. Thiagarajan
Circulation 2003;108:2082-2087; published online before print as doi:10.1161/01.CIR.0000095030.44185.6A
[Abstract]
[Full text]
- Basic Science Reports
Dose-Dependent Acceleration of High-Density Lipoprotein Catabolism by Endothelial Lipase
- Cyrille Maugeais, Uwe J.F. Tietge, Uli C. Broedl, Dawn Marchadier, William Cain, Mary G. McCoy, Sissel Lund-Katz, Jane M. Glick, and Daniel J. Rader
Circulation 2003;108:2121-2126; published online before print as doi:10.1161/01.CIR.0000092889.24713.DC
[Abstract]
[Full text]
- Cardiology Patient Pages
Kidney Failure and Cardiovascular Disease
- Kevin C. Abbott and George L. Bakris
Circulation 2003;108:e114-115e, doi:10.1161/01.CIR.0000097492.23343.A4
[Full text]
- Clinical Investigations and Reports
Association Between Apolipoprotein E Alleles and Calcific Valvular Heart Disease
- Gian M. Novaro, Ravish Sachar, Gregory L. Pearce, Dennis L. Sprecher, and Brian P. Griffin
Circulation 2003;108:1804-1808; published online before print as doi:10.1161/01.CIR.0000097560.96431.3E
[Abstract]
[Full text]
- Clinical Investigations and Reports
Association Between Apolipoprotein E Alleles and Calcific Valvular Heart Disease
- Gian M. Novaro, Ravish Sachar, Gregory L. Pearce, Dennis L. Sprecher, and Brian P. Griffin
Circulation published October 6, 2003, doi:10.1161/01.CIR.0000097560.96431.3E
[Abstract]
[Full text]
- Articles
Sulfatides. Targets for Anti-Phospholipid Antibodies
- M. Merten, S. Motamedy, S. Ramamurthy, F. C. Arnett, and P. Thiagarajan
Circulation published October 6, 2003, doi:10.1161/01.CIR.0000095030.44185.6A
[Abstract]
- Clinician Update
The Metabolic Syndrome: A Practical Guide to Origins and Treatment: Part II
- Peter W.F. Wilson and Scott M. Grundy
Circulation 2003;108:1537-1540, doi:10.1161/01.CIR.0000089506.12223.F1
[Full text]
- Clinical Investigations and Reports
High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study
- Scott Kinlay, Gregory G. Schwartz, Anders G. Olsson, Nader Rifai, Sally J. Leslie, William J. Sasiela, Michael Szarek, Peter Libby, Peter Ganz for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Circulation 2003;108:1560-1566; published online before print as doi:10.1161/01.CIR.0000091404.09558.AF
[Abstract]
[Full text]
- Articles
Dose-Dependent Acceleration of High-Density Lipoprotein Catabolism by Endothelial Lipase
- Cyrille Maugeais, Uwe J.F. Tietge, Uli C. Broedl, Dawn Marchadier, William Cain, Mary G. McCoy, Sissel Lund-Katz, Jane M. Glick, and Daniel J. Rader
Circulation published September 29, 2003, doi:10.1161/01.CIR.0000092889.24713.DC
[Abstract]
- Clinician Update
The Metabolic Syndrome: Practical Guide to Origins and Treatment: Part I
- Peter W. F. Wilson and Scott M. Grundy
Circulation 2003;108:1422-1424, doi:10.1161/01.CIR.0000089505.34741.E5
[Full text]
|
|
